Showing results (61-70 of 2,567) with videos related to
Sort By:
Pageof 257
The Oncologist|December 13, 2003
Modifications to therapy for multiple myeloma: pegylated liposomal Doxorubicin in combination with vincristine, reduced-dose dexamethasone, and thalidomideMohamad A HusseinMedical Oncology (Northwood, London, England)|March 29, 2002
Arsenic trioxide: a new immunomodulatory agent in the management of multiple myelomaM A HusseinThe Oncologist|April 19, 2002
Nontraditional cytotoxic therapies for relapsed/refractory multiple myelomaMohamad A HusseinTransfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 4, 2020
Idiopathic TTP in the Middle East: Epidemiology and clinical outcomes in infection associated episodesEiman A HusseinTAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|January 14, 2014
Seed protein traits of fasciated pea recombinants and the role of the mutant genes involvedH A HusseinJournal of National Black Nurses' Association : JNBNA|January 1, 1989
Black America year 2000: challenges of tomorrowC A HusseinRSC Advances|May 2, 2022
Ru-catalysed oxidative cyclisation of 1,5-dienes: an unprecedented role for the co-oxidantAqeel A HusseinSeminars in Hematology|December 14, 2005
Lenalidomide: patient management strategiesMohamad A HusseinJournal of the National Comprehensive Cancer Network : JNCCN|March 6, 2007
Multiple myeloma: most common end-organ damage and managementMohamad A HusseinExpert Review of Anticancer Therapy|March 11, 2005
Thalidomide: present and future in multiple myelomaMohamad A HusseinPageof 257